Re-evaluating the predictive roles of metabolic complications and clinical outcome according to eGFR levels — a four-years prospective cohort study in Taiwan

Table 2 eGFR thresholds associated with metabolic complications with a sensitivity of 90%

Complications	eGFR, mL/min/1.73 m2	Specificity	eGFR, mL/min/1.73 m2	Specificity
Complications	(Abbreviated MDRD)	%	(CKD-EPI)	%
Hyperphosphatemia	55.3	28	86.3	64
Hyperparathyroidism	35.8	50	39.9	53
Anemia	40.5	58	44.2	64
Hyperuricemia	39.1	35	45.6	33
Hyperkalemia	41	31	40.1	36
Hypoalbuminemia	32.9	45	35.4	45
Acidosis	29.8	59	27.8	59
Microinflammation	43.3	26	57.8	21

eGFR, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration.